Ilaria Pergolini

Ilaria Pergolini

Auto-generated profile, based on publicly available information

Ilaria Pergolini

Department of Surgery TUM Universitätsklinikum Klinikum Rechts der Isar Technische Universität München Munich Germany

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 May 2019 in BJS Open
Verified
Journal Article
Open access
PDF file
IPI. Pergolini
I. Pergolini
SCS. Crippa
S. Crippa
MPM. Pagnanelli
M. Pagnanelli
GBG. Belfiori
G. Belfiori
APA. Pucci
A. Pucci
MFMassimo Falconi
Massimo Falconi
Background Pancreatic ductal adenocarcinoma (PDAC) is an aggressive disease characterized by complex biological features and poor prognosis. A prognostic stratification of PDAC would help to improve patient management. The aim of this study was to analyse the expression of Ki‐67 in relation to prognosis in a cohort of patients with PDAC who had surgical treatment. Methods Patients who had pancreatic resection between August 2010 and October 2014 for PDAC at two Italian centres were reviewed retrospectively. Patients with metastatic or locally advanced disease, those who received neoadjuvant chemotherapy, patients with PDAC arising from intraductal papillary mucinous neoplasm and those with missing data were excluded. Clinical and pathological data were retrieved and analysed. Ki‐67 expression was evaluated using immunohistochemistry and patients were stratified into three subgroups. Survival analyses were performed for disease‐free (DFS) and disease‐specific (DSS) survival outcomes according to Ki‐67 expression and tumour grading. Results A total of 170 patients met the selection criteria. Ki‐67 expression of 10 per cent or less, 11–50 per cent and more than 50 per cent significantly correlated with DFS and DSS outcomes (P = 0·016 and P = 0·002 respectively). Ki‐67 index was an independent predictor of poor DFS (hazard ratio (HR) 0·52, 95 per cent c.i. 0·29 to 0·91; P = 0·022) and DSS (HR 0·53, 0·31 to 0·91; P = 0·022). Moreover, Ki‐67 index correlated strongly with tumour grade (P < 0·001). Patients with PDAC classified as a G3 tumour with a Ki‐67 index above 50 per cent had poor survival outcomes compared with other patients (P < 0·001 for both DFS and DSS). Conclusion Ki‐67 index could be of use in predicting the survival of patients with PDAC. Further investigation in larger cohorts is needed to validate these results.

1 February 2021 in Surgery
Verified
Journal Article
Closed access
IPIlaria Pergolini
Ilaria Pergolini
SSStephan Schorn
Stephan Schorn
CJCarsten Jäger
Carsten Jäger
RGRüdiger Göß
Rüdiger Göß
ANAlexander Novotny
Alexander Novotny
IDI.Ekin Demir
I.Ekin Demir

1 February 2018 in Journal of Gastrointestinal Surgery
Verified
Journal Article
Closed access
PDF file
VMVicente Morales-Oyarvide
Vicente Morales-Oyarvide
MMMari Mino-Kenudson
Mari Mino-Kenudson
CFCristina R. Ferrone
Cristina R. Ferrone
AWAndrew L. Warshaw
Andrew L. Warshaw
KLKeith D. Lillemoe
Keith D. Lillemoe
CCCarlos Fernández-Del Castillo
Carlos Fernández-Del Castillo

5 January 2022 in Surgery
Verified
Journal Article
Open access
IPIlaria Pergolini
Ilaria Pergolini
SSStephan Schorn
Stephan Schorn
RGRüdiger Goess
Rüdiger Goess
ANAlexander Novotny
Alexander Novotny
GCGüralp O. Ceyhan
Güralp O. Ceyhan
AZA Zerbi
A Zerbi
Drain use in pancreatic surgery remains controversial. This survey sought to evaluate habits, experiences, and opinions of experts in the field on the use of drains to provide interesting insights for pancreatic surgeons worldwide. An online survey designed via Google Forms was sent in December 2020 to experienced surgeons of the International Study Group for Pancreatic Surgery. Forty-two surgeons (42/63, 67%) completed the survey. During their career, 74% (31/42) performed personally >500 pancreatic resections; of these, 9 (21%) >1,500. Sixty-nine percent of the respondents (29/42) declared to always use drains during pancreatic resections and 17% (7/42) in >50% of the operations. For these participants, the use of drains does not increase but reduces the risk of pancreatic fistula and other complications, and more importantly, helps to detect them earlier and manage them better. By contrast, 2 surgeons (5%) declared to never apply drains, whereas other 4 (10%) use drains only in selective cases, deeming that drains increase the risk of infection and other complications. When applied, drains are managed very heterogeneously as for the type of drains, enzyme testing, and removal schedules. Four participants declared to practice continuous irrigation. Twenty-two surgeons (55%) remove drains routinely within the third postoperative day, other 11 (27.5%) only in selected cases, whereas 7 (17.5%) normally keep drains longer. Despite plenty of publications on this topic, drain management in pancreatic surgery remains very heterogeneous. Safety and the surgeon´s personal experience seem to play a determining role.

1 January 2021 in Clinical Gastroenterology and Hepatology
Verified
Journal Article
Open access
IPIlaria Pergolini
Ilaria Pergolini
CJCarsten Jäger
Carsten Jäger
OSOkan Safak
Okan Safak
RGRüdiger Göß
Rüdiger Göß
ANAlexander Novotny
Alexander Novotny
IDI.Ekin Demir
I.Ekin Demir
The role of diabetes in intraductal papillary mucinous neoplasms (IPMNs) is not known. We investigated the prevalence of diabetes among patients with resected IPMNs and the association between diabetes, clinical and morphological features, and high-grade dysplasia or invasive cancer. We collected clinical, pathology, laboratory, and demographic data from 134 patients who underwent pancreatic resection for IPMN from a referral center in Germany. We identified 50 patients with diabetes (37%). Higher proportions of patients with diabetes were male and older, but did not have increased body mass index, compared to patients without diabetes. Diabetes was significantly associated with main-duct involvement (odds ratio [OR], 2.827; 95% CI, 1.059-7.546; P = .038) and high-grade dysplasia or invasive carcinoma (OR, 2.692; 95% CI, 1.283-5.651; P = .009). Risk of high-grade dysplasia or invasive cancer was even higher in patients with new-onset or worsening diabetes (OR, 4.615; 95% CI, 1.423-14.698; P = .011). Fifty-eight percent of patients (18/31) with weight loss at diagnosis had diabetes vs 32% of patients (31/97) without weight loss (P = .009). However, when the analysis was restricted to IPMNs with low-grade dysplasia, weight loss and diabetes were no longer associated (42% [5/12] vs 21% [9/44]; P = .133). In patients with IPMNs, diabetes is associated with increased risk of main duct involvement and high-grade dysplasia or invasive carcinoma. Studies are needed to determine the relationship between diabetes and progression of IPMNs, which might lead to strategies for early detection and prevention of invasive cancer. Findings from this study should be considered in the guidelines for management of IPMN.

26 June 2025 in Cancer Letters
Verified
Journal Article
Open access
KÇKaan Çifcibaşı
Kaan Çifcibaşı
RGRuediger Goess
Ruediger Goess
EMEnkhtsetseg Munkhbaatar
Enkhtsetseg Munkhbaatar
IPIlaria Pergolini
Ilaria Pergolini
CJCarsten Jäger
Carsten Jäger
CRCarmen Mota Reyes
Carmen Mota Reyes